They found that the median survival for LAMN-NEP patients was significantly lower if they were treated with CRS plus HIPEC+EPIC compared to those treated with CRS plus HIPEC, while the median survival for LAMN-NEA patients showed a trend of better survival if they were treated with CRS plus HIPEC+EPIC, although the effect was not statistically significant [ 17 , 18 , 19 ].
← all excerpts
Low-Grade Pseudomyxoma Peritonei Behaving as a High-Grade Disease: A Case Series and Literature Review.
1
—
—